The overarching goal of this revised NRSA application is to provide a high quality mentored training experience for those future clinical cardiovascular researchers who have the potential to become the thought leaders of the next generation. The proposed training program will allow us to attract the best post-doctoral fellows into clinical research and ensure a high rate of retention of these fellows in academics after completion of training. By achieving the goal of the program, we will address the national priority of developing academic clinical researchers who can fill vital roles along the gamut of research priorities from bench to bedside, and include translational researchers as well as clinical trialists and outcomes researchers. The three objectives of this NRSA training program in clinical cardiovascular research are to provide trainees with: 1) didactic training in the methods of clinical research, 2) a mentored research experience, and 3) training and experience in """"""""survival skills"""""""" required for a successful academic career. Trainees will spend at least 2 years in this program and devote 100% effort to the program while they are in it. We are requesting 6 trainee slots at the post-doctoral level. Formal training of participating mentors on the essentials of good mentoring will be a major feature of our program. Interdisciplinary co-mentoring will be encouraged. Twenty-one faculty representing 5 Departments at Duke (Medicine, Surgery, Anesthesiology, Pediatrics, Behavioral Medicine/Psychiatry) will participate as mentors in this program. They are organized into three general research tracks: translational (patient-oriented), clinical trials, and outcomes. These three tracks will be distinguished by the program of didactic course work chosen and the customized mentored research program created for each trainee. During the course of each fellowship, several methods will be used to monitor progress, including quarterly meetings for each fellow with the Program Director. Outcomes expected from each fellow accepted into this NRSA program that will be used to assess progress will include presentations at Duke research conferences and at national meetings, peer-reviewed publications, and at least one grant application to support the trainee's post-fellowship research. Particular emphasis will be given by the Program Director and faculty to assisting each fellow to obtain a post-fellowship faculty position in academics that will allow continuation of their research work. Program graduates will also be monitored with annual contacts to ensure continued success and establishment of a stable academic career. The proposed NRSA program will organize the abundant resources available at Duke for clinical research into a focused and efficient program for training the clinical cardiovascular thought leaders of the future.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
1T32HL069749-01A1
Application #
6593152
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F3))
Program Officer
Schucker, Beth
Project Start
2003-07-01
Project End
2008-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
1
Fiscal Year
2003
Total Cost
$195,692
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Greene, Stephen J; Mentz, Robert J; Fiuzat, Mona et al. (2018) Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure. Circulation 138:1039-1053
Ambrosy, Andrew P; Mentz, Robert J; Fiuzat, Mona et al. (2018) The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions. Eur J Heart Fail 20:963-972
Greene, Stephen J; Felker, G Michael; Butler, Javed (2018) Outpatient versus inpatient worsening heart failure: distinguishing biology and risk from location of care. Eur J Heart Fail :
Greene, Stephen J; Mentz, Robert J (2018) Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'? Eur J Heart Fail 20:471-473
Mandawat, Aditya; Newby, L Kristin (2018) High-Sensitivity Troponin in Noncardiac Surgery: Pandora's Box or Opportunity for Precision Perioperative Care? Circulation 137:1233-1235
Greene, Stephen J; Fonarow, Gregg C; Solomon, Scott D et al. (2018) Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial. Eur J Heart Fail :
Zeitler, Emily P; Sanders, Gillian D; Singh, Kavisha et al. (2018) Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis. Europace 20:1621-1629
Greene, Stephen J; Felker, G Michael (2018) Considering the duration of heart failure: using the past to predict the future. Eur J Heart Fail 20:382-384
Vaduganathan, Muthiah; Patel, Ravi B; Mentz, Robert J et al. (2018) Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial). Am J Cardiol 122:255-260
Greene, Stephen J; Vaduganathan, Muthiah; Khan, Muhammad Shahzeb et al. (2018) Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes. J Am Coll Cardiol 71:1379-1390

Showing the most recent 10 out of 186 publications